Stockreport

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [Read more]